Antiviral therapy in patients with chronic hepatitis B and hepatocellular carcinoma: post-thermal ablation. Better late than never? Eugene R. Schiff Editorial 05 December 2007 Pages: 1 - 2
Immune selection during chronic hepadnavirus infection William S. MasonSam LitwinAllison R. Jilbert Review Article 14 December 2007 Pages: 3 - 16
Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review Ryosuke TateishiHaruhiko YoshidaMasao Omata ORIGINAL ARTICLE 29 December 2007 Pages: 17 - 30
Models for prediction of mortality from cirrhosis with special reference to artificial neural network: a critical review Uday Chand GhoshalAnanya Das Review Article 27 November 2007 Pages: 31 - 38
Genome-wide transcriptome expression in the liver of a mouse model of high carbohydrate diet-induced liver steatosis and its significance for the disease Ion V. DeaciucZhenyuan SongCraig J. McClain Original Research 27 November 2007 Pages: 39 - 49
Stage-specific regulation of adhesion molecule expression segregates epithelial stem/progenitor cells in fetal and adult human livers Mari InadaDaniel BentenSanjeev Gupta Original Research 27 November 2007 Pages: 50 - 62
Thy1-positive bone marrow stem cells express liver-specific genes in vitro and can mature into hepatocytes in vivo Si Hyun BaeJong Young ChoiBryon E. Petersen OriginalPaper 27 November 2007 Pages: 63 - 71
Correction of copper metabolism is not sustained long term in Wilson’s disease mice post bone marrow transplantation Nicole E. BuckDaphne M. Y. CheahKatrina J. Allen Original Article 28 December 2007 Pages: 72 - 79
Adeno-associated virus vector-mediated production of hepatocyte growth factor attenuates liver fibrosis in mice Kazuhiro SuzumuraTadamichi HiranoJiro Fujimoto ORIGINAL ARTICLE 22 December 2007 Pages: 80 - 88
Safety and efficacy of lamivudine after radiofrequency ablation in patients with hepatitis B virus-related hepatocellular carcinoma Hideo YoshidaHaruhiko YoshidaMasao Omata OriginalPaper 26 September 2007 Pages: 89 - 94
Gender-based outcomes differences in unresectable hepatocellular carcinoma Shama C. BuchVenkateswarlu KondraguntaBrian I. Carr Original Article 15 December 2007 Pages: 95 - 101
Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B Teerha PiratvisuthGeorge LauMatei Popescu ORIGINAL ARTICLE 05 February 2008 Pages: 102 - 110
Blood cell, liver function, and response changes by PEG-interferon-α2b plus ribavirin with polaprezinc therapy in patients with chronic hepatitis C Ke Ih KimSoo Ryang KimKazuhiko Tanaka OriginalPaper 11 January 2008 Pages: 111 - 115
Insufficient radiofrequency ablation therapy may induce further malignant transformation of hepatocellular carcinoma Koichi ObaraNobuyuki MatsumotoFumio Itoh Original Article 29 January 2008 Pages: 116 - 123
Noninvasive predictors of large varices in patients hospitalized with gastroesophageal variceal hemorrhage Faisal Wasim IsmailHasnain A. ShahWasim Jafri Original Article 14 December 2007 Pages: 124 - 128
Small-cell carcinoma of the extrahepatic bile duct: a case report and review of the literature Kenichi HosonumaKen SatoMasatomo Mori Case Report 18 December 2007 Pages: 129 - 132
Actinomycotic hepatic abscess Arzu TiftikciEser N. VardareliNurdan Tozun Report 29 November 2007 Pages: 133 - 135
Efficacy and safety of entecavir compared to lamivudine in nucleoside-naïve patients with chronic hepatitis B: a randomized double-blind trial in China Guangbi YaoChengwei Chenfor the AI463023 Study Group Erratum 12 January 2008 Pages: 136 - 136
